Efficacy and Safety Comparison of two different topical gels (one active and one vehicle) in combination with an oral antibiotic in the treatment of Moderate to Severe Acne Vulgaris.
Phase 3
- Conditions
- AcneSkin - Dermatological conditions
- Registration Number
- ACTRN12609000443291
- Lead Sponsor
- Galderma Australia Pty Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 360
Inclusion Criteria
Male or female Subjects of any race, between the age of 12
and 35 years inclusive, with moderate to severe acne
vulgaris, meeting specific inclusion/exclusion criteria.
Exclusion Criteria
Subjects with more than 3 nodules or cysts on the face
2. Subjects with acne conglobata, acne fulminans, secondary acne (chloracne, drug-induced
acne, etc.),
3. Female Subjects who are pregnant, nursing or planning a pregnancy during the study,
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method